Phase 1 Clinical Trial of Human Hookworm Vaccine Successfully Completed

WASHINGTON, D.C. — September 3, 2014 — The Sabin Vaccine Institute (Sabin) today announced that its product development partnership (Sabin PDP) successfully completed a Phase 1 clinical trial in Brazil of Na-GST-1/Alhydrogel®, a vaccine candidate for human hookworm, one of the most pervasive neglected tropical diseases (NTDs) affecting the world’s poor. The Sabin PDP is based at Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine in Houston, Texas.

Eleventh International Rotavirus Symposium Held in New Delhi, India

New Delhi, India — September 3, 2014 — The Eleventh International Rotavirus Symposium today began just two months after Indian Prime Minister Narendra Modi announced that the Government of India would provide a rotavirus vaccine to all Indian children, and weeks before the highly anticipated UN General Assembly’s 69th opening session, which will assess progress towards the Millennium Development Goals (MDGs).
Dr. Eka Paatashvili recently joined the Sustainable Immunization Financing (SIF) team as a Senior Program Officer (SPO). She will be based in Tbilisi, Georgia and will be responsible for program activities in Armenia, Georgia, Moldova and Uzbekistan. A physician by training, Eka previously worked in the Georgia Ministry of Labor, Health and Social Affairs in the areas of program management and procurement, finance and budget reform, and regulatory affairs. From there she earned an Executive Master of Public Administration degree from Syracuse University, where her research compared the Georgian and American health care systems, and she developed effective paradigms of collaborative governance.

Al Jazeera Lifelines, a project which is profiling past and current global health workers who go above and beyond their duties,

Last week, researchers, academics, doctors and advocates from all over the world gathered in Mexico City, Mexico at the 13th International Congress of Parasitology (ICOPA). Sabin Vaccine Institute (Sabin) President Dr.

The accomplishments and work of Sabin and its three major programs — Vaccine Advocacy & Education, the Sabin Product Development Partnership (Sabin PDP) and the Global Network for Neglected Tropical Diseases (Global Network) — are highlighted in our 2013 Annual Report.

Pages